Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Dermatology

Understanding Your Frontal Fibrosing Alopecia Diagnosis

At a Glance

Frontal fibrosing alopecia is an inflammatory scarring hair-loss condition that can permanently destroy affected follicles. Treatment cannot restore scarred hair, but early care can calm inflammation and help keep the hairline and eyebrows from receding further.

Discovering that your hairline is receding or that your eyebrows are thinning can be a deeply unsettling experience. When you receive a diagnosis of Frontal Fibrosing Alopecia (FFA), it is common to feel a sense of shock or even guilt as you search for reasons why this is happening. Understanding the biology of this condition and the goals of modern care can help you move from a place of uncertainty toward an informed plan for managing your hair health.

What is Frontal Fibrosing Alopecia?

FFA is a type of scarring alopecia (permanent hair loss) characterized by a slow, progressive recession of the front and sides of the hairline [1][2]. In many cases, the first sign is not the hairline at all, but a thinning or complete loss of the eyebrows [3].

Biologically, FFA occurs because your immune system is thought to involve an inflammatory attack on your hair follicles. Specifically, immune cells called CD8+ cytotoxic T-cells gather around the “bulge” of the hair follicle [4][5]. The bulge is a critical area because it houses the follicular stem cells responsible for regenerating hair [6]. When these T-cells attack, they cause inflammation that destroys these stem cells and replaces the healthy follicle with fibrous scar tissue [7][4]. Because the stem cells are lost in this process, the hair follicle can no longer produce new hair, making the loss permanent in those specific areas [8][9]. It is important to note that not every thinning hair is irreversibly destroyed, but true scarring is permanent.

The Link to Lichen Planopilaris

You may hear your doctor mention a related condition called Lichen Planopilaris (LPP). Most experts believe that FFA and LPP are “cousins” or different variants of the same underlying disease spectrum [10][6].

  • Lichen Planopilaris (LPP): Typically causes patchy areas of hair loss anywhere on the scalp [2].
  • Frontal Fibrosing Alopecia (FFA): Follows a specific pattern, primarily affecting the front of the hairline and the eyebrows [3].

While they look different on the scalp, when a piece of skin is examined under a microscope (biopsy), the two conditions can look nearly identical [11][12]. Both involve a similar type of immune cell inflammation around the hair follicle [10].

Who Gets FFA?

For a long time, FFA was thought to almost exclusively affect women after menopause. We now know that while postmenopausal women make up the largest group of patients, the condition can affect anyone [1].

  • Menopause and Age: The average age at diagnosis is around 60, but approximately 21% of women diagnosed are premenopausal [1][13].
  • Men and Diverse Backgrounds: Men can also develop FFA, often losing their beard hair or sideburns along with their hairline [14][15]. It is also increasingly recognized in people of all ethnic backgrounds, including those of African and Asian descent [15][8][16].

The Sunscreen and Cosmetic Controversy

As you research FFA, you will likely encounter theories linking it to the use of sunscreens or facial moisturizers. Some studies have found that people with FFA report using these products more often than people without the condition [14][17]. However, this does not mean that sunscreen causes FFA.

Current medical consensus highlights several important points:

  1. No Proven Cause: There is no confirmed evidence that sunscreen or any cosmetic product directly triggers the immune attack in FFA [8][18].
  2. Potential for Bias: People with early signs of FFA (like skin redness or thinning hair) might be more likely to use facial products or sun protection to manage their symptoms, making it look like the products came first (a phenomenon called reverse causation) [19][16].
  3. Inconsistent Data: Several large, well-designed studies have found no association at all between sunscreen use and FFA [20][21].

It is vital that you do not blame yourself or your skincare routine for this diagnosis. Because the link is unproven, dermatologists generally do not recommend that you stop using sun protection, which remains essential for preventing skin cancer [8][22].

Shifting the Goal: From Regrowth to Stability

The most difficult part of an FFA diagnosis is accepting that hair already lost to scarring cannot grow back [8]. However, this does not mean that treatment is useless.

The primary goal of therapy is stabilization—halting the inflammation to protect the hair you still have [9]. Your care team will monitor for signs of “active” disease, such as:

  • Peripilar casts: Small tubes of scale that wrap around the base of hair shafts [3].
  • Erythema: Redness around the hair follicles at the edge of the hairline [23].
  • Progression: Measured by taking careful measurements or photographs over time to see if the hairline is moving [24][25].

Success in treating FFA is often defined by “nothing happening”—meaning your hairline stays exactly where it is today [9][26]. By catching the condition early and using treatments to calm the immune response, you and your doctor can work to preserve your current hairline for the long term.

Common questions in this guide

What does a frontal fibrosing alopecia diagnosis mean?
Frontal fibrosing alopecia is a scarring form of hair loss that usually slowly recedes the front and sides of the hairline and may thin or remove the eyebrows. In areas where inflammation has replaced a hair follicle with scar tissue, the hair loss is permanent.
Can hair lost from frontal fibrosing alopecia grow back?
Hair follicles replaced by scar tissue cannot produce new hair, so regrowth in truly scarred areas is not expected. Treatment can protect follicles that are still working and help prevent or slow further hairline recession.
Is frontal fibrosing alopecia the same as lichen planopilaris?
They are considered related forms of the same disease spectrum and can look very similar when a biopsy is examined. Frontal fibrosing alopecia usually follows the front hairline and eyebrows, while lichen planopilaris more often causes patchy scalp hair loss.
Does sunscreen or moisturizer cause frontal fibrosing alopecia?
There is no confirmed evidence that sunscreen or cosmetic products directly cause the immune attack involved in frontal fibrosing alopecia. Because the research is inconsistent, dermatologists generally do not recommend stopping sun protection solely because of this diagnosis.
How do doctors know whether frontal fibrosing alopecia is still active?
Doctors look for signs such as redness, scaling, small tubes of scale around hair shafts, or continued movement of the hairline. Trichoscopy, measurements, standardized photographs, and sometimes a scoring system can help track changes over time.
What is the main goal of treatment for frontal fibrosing alopecia?
The usual goal is to calm inflammation and stabilize the condition so that remaining hair is protected. Treatment is generally aimed at preventing further loss rather than regrowing hair in areas already replaced by scar tissue.
Can men or premenopausal women develop frontal fibrosing alopecia?
Yes. Although frontal fibrosing alopecia is diagnosed most often in postmenopausal women, it can affect men, premenopausal women, and people of any ethnic background. Men may also notice loss of beard hair or sideburns.

Get notified when new evidence is published on Frontal fibrosing alopecia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Frontal Fibrosing Alopecia: An Observational Single-Center Study of 306 Cases.

    Carmona-Rodríguez M, Moro-Bolado F, Romero-Aguilera G, et al.

    Life (Basel, Switzerland) 2023; (13(6)) doi:10.3390/life13061344.

    PMID: 37374126
  2. 2

    Frontal fibrosing alopecia.

    Kerkemeyer KLS, Eisman S, Bhoyrul B, et al.

    Clinics in dermatology 2021; (39(2)):183-193 doi:10.1016/j.clindermatol.2020.10.007.

    PMID: 34272007
  3. 3

    Clinical and Dermoscopic Approaches to Diagnosis of Frontal Fibrosing Alopecia: Results From a Multicenter Study of the International Dermoscopy Society.

    Starace M, Orlando G, Iorizzo M, et al.

    Dermatology practical & conceptual 2022; (12(1)):e2022080 doi:10.5826/dpc.1201a80.

    PMID: 35223189
  4. 4

    Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing.

    Del Duca E, Ruano Ruiz J, Pavel AB, et al.

    The British journal of dermatology 2020; (183(6)):1083-1093 doi:10.1111/bjd.19040.

    PMID: 32215911
  5. 5

    Inflammatory features of frontal fibrosing alopecia.

    Ma SA, Imadojemu S, Beer K, Seykora JT

    Journal of cutaneous pathology 2017; (44(8)):672-676 doi:10.1111/cup.12955.

    PMID: 28429464
  6. 6

    Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

    Senna MM, Peterson E, Jozic I, et al.

    JID innovations : skin science from molecules to population health 2022; (2(3)):100113 doi:10.1016/j.xjidi.2022.100113.

    PMID: 35521043
  7. 7

    Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases.

    Harries MJ, Jimenez F, Izeta A, et al.

    Trends in molecular medicine 2018; (24(5)):435-448 doi:10.1016/j.molmed.2018.03.007.

    PMID: 29661566
  8. 8

    Frontal Fibrosing Alopecia: An Update.

    Messenger AG, Asfour L, Harries M

    American journal of clinical dermatology 2025; (26(2)):155-174 doi:10.1007/s40257-024-00912-w.

    PMID: 39699852
  9. 9

    Frontal fibrosing alopecia: efficacy of treatment modalities.

    Gamret AC, Potluri VS, Krishnamurthy K, Fertig RM

    International journal of women's health 2019; (11()):273-285 doi:10.2147/IJWH.S177308.

    PMID: 31118828
  10. 10

    Profiling the human hair follicle immune system in lichen planopilaris and frontal fibrosing alopecia: can macrophage polarization differentiate these two conditions microscopically?

    Harries M, Hardman J, Chaudhry I, et al.

    The British journal of dermatology 2020; (183(3)):537-547 doi:10.1111/bjd.18854.

    PMID: 31883384
  11. 11

    Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab.

    Trindade de Carvalho L, Meah N, Wall D, Sinclair R

    Dermatologic therapy 2020; (33(4)):e13694 doi:10.1111/dth.13694.

    PMID: 32458516
  12. 12

    Lichen planopilaris and frontal fibrosing alopecia cannot be differentiated by histopathology.

    Gálvez-Canseco A, Sperling L

    Journal of cutaneous pathology 2018; (45(5)):313-317 doi:10.1111/cup.13112.

    PMID: 29369400
  13. 13

    Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre.

    Starace M, Brandi N, Alessandrini A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(2)):433-438 doi:10.1111/jdv.15372.

    PMID: 30472804
  14. 14

    Frontal fibrosing alopecia and personal care product use: a systematic review and meta-analysis.

    Kam O, Na S, Guo W, et al.

    Archives of dermatological research 2023; (315(8)):2313-2331 doi:10.1007/s00403-023-02604-7.

    PMID: 37014396
  15. 15

    Diagnostic Clues to Frontal Fibrosing Alopecia in Patients of African Descent.

    Callender VD, Reid SD, Obayan O, et al.

    The Journal of clinical and aesthetic dermatology 2016; (9(4)):45-51.

    PMID: 27721910
  16. 16

    Use of facial care products and frontal fibrosing alopecia: Coincidence or true association?

    Leecharoen W, Thanomkitti K, Thuangtong R, et al.

    The Journal of dermatology 2021; (48(10)):1557-1563 doi:10.1111/1346-8138.16063.

    PMID: 34264523
  17. 17

    Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study.

    Aldoori N, Dobson K, Holden CR, et al.

    The British journal of dermatology 2016; (175(4)):762-7 doi:10.1111/bjd.14535.

    PMID: 26987767
  18. 18

    Sunscreen and frontal fibrosing alopecia: A review.

    Robinson G, McMichael A, Wang SQ, Lim HW

    Journal of the American Academy of Dermatology 2020; (82(3)):723-728 doi:10.1016/j.jaad.2019.09.085.

    PMID: 31654665
  19. 19

    Frontal Fibrosing Alopecia and Sunscreen Use: A Cross-sectional Study of Actinic Damage.

    Porriño-Bustamante ML, Montero-Vílchez T, Pinedo-Moraleda FJ, et al.

    Acta dermato-venereologica 2022; (102()):adv00757 doi:10.2340/actadv.v102.306.

    PMID: 35604235
  20. 20

    Risk factors for frontal fibrosing alopecia: A case-control study in a multiracial population.

    Ramos PM, Anzai A, Duque-Estrada B, et al.

    Journal of the American Academy of Dermatology 2021; (84(3)):712-718 doi:10.1016/j.jaad.2020.08.076.

    PMID: 32835739
  21. 21

    Hair Care Habits and Frontal Fibrosing Alopecia: A Case-Control Study.

    Ko EA, Cappetta ME, Rangel M, et al.

    Skin appendage disorders 2025; doi:10.1159/000549427.

    PMID: 41409529
  22. 22

    Hair Shaft Morphology, Elemental Composition, and Nanoparticles in Frontal Fibrosing Alopecia: A Case-control Study.

    Lyakhovitsky A, Kartvelishvily E, Drousiotis T, et al.

    Acta dermato-venereologica 2021; (101(9)):adv00541 doi:10.2340/00015555-3891.

    PMID: 34396423
  23. 23

    Frontal Fibrosing Alopecia Severity Index: A Trichoscopic Visual Scale That Correlates Thickness of Peripilar Casts with Severity of Inflammatory Changes at Pathology.

    Martínez-Velasco MA, Vázquez-Herrera NE, Misciali C, et al.

    Skin appendage disorders 2018; (4(4)):277-280 doi:10.1159/000487158.

    PMID: 30410896
  24. 24

    Development and validation of the Frontal Fibrosing Alopecia Severity Score.

    Saceda-Corralo D, Moreno-Arrones ÓM, Fonda-Pascual P, et al.

    Journal of the American Academy of Dermatology 2018; (78(3)):522-529 doi:10.1016/j.jaad.2017.09.034.

    PMID: 28947289
  25. 25

    Trichoscopy-Derived Hairline Recession Equivalent in Monitoring Frontal Fibrosing Alopecia.

    Sicińska J, Kasprzak M, Walecka I

    Skin appendage disorders 2022; (8(5)):362-367 doi:10.1159/000524127.

    PMID: 36161086
  26. 26

    Consensus Document on the Clinical Management of Frontal Fibrosing Alopecia: Recommendations From Spanish Working Group on Trichology and Onychology of the AEDV.

    Saceda-Corralo D, Combalia A, Fernandez-Crehuet P, et al.

    Actas dermo-sifiliograficas 2025; (117(1)):104486 doi:10.1016/j.ad.2025.104486.

    PMID: 41344613

This page is for informational purposes only and does not constitute medical advice. Your dermatologist can assess whether your frontal fibrosing alopecia is active and tailor monitoring and treatment to your situation.

Guide contents Frontal fibrosing alopecia
Research & Literature
02 Symptoms, Progression, and Look-Alike Conditions